Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
California
Research
Massachusetts most impacted by NIH research cuts: Grant Witness
Massachusetts has lost over $1.3 billion in terminated research grants from the NIH, making it one of the most impacted states by the federal cuts.
Gabrielle Masson
Sep 18, 2025 9:38am
Amgen unveils plans for $600M R&D site in California
Sep 2, 2025 11:08am
Gilead lays off 36 people after axing Oceanside expansion plan
Jun 16, 2025 9:53am
CSL Behring shuts down California cell and gene therapy R&D site
Nov 18, 2024 8:35am
BMS closes Redwood City cell therapy research site
Apr 26, 2024 10:59am
FDA warns of pregnancy, UTI tests from unlicensed California lab
Aug 14, 2023 11:03am